Jun 26, 2024 05:26AM
Jun 18, 2024 08:45AM
May 14, 2024 07:30AM
Apr 9, 2024 07:07AM
Apr 9, 2024 07:00AM
Mar 25, 2024 07:03AM
Mar 25, 2024 07:00AM Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
May 10, 2023 07:30AM
Mar 2, 2023 07:30AM
Jan 26, 2023 07:05AM
Jan 26, 2023 07:00AM
Nov 14, 2022 07:30AM
Sep 13, 2022 04:01PM
Sep 13, 2022 04:01PM Syros Receives FDA Orphan Drug Designation for SY-5609 for the Treatment of Pancreatic Cancer
Sep 12, 2022 05:48PM
Aug 9, 2022 07:30AM
Aug 3, 2022 04:03PM
Aug 3, 2022 04:01PM
May 16, 2022 07:30AM
Mar 15, 2022 07:32AM
Feb 2, 2022 04:35PM Syros Pharmaceuticals (SYRS) Confirms FDA Orphan Drug Designation for Tamibarotene for the Treatment of MDS
Feb 2, 2022 04:01PM
Feb 1, 2022 11:47AM
Jan 10, 2022 07:00AM
Sep 29, 2021 08:00AM
Jan 20, 2021 09:20AM
Jan 19, 2021 05:44PM
Dec 7, 2020 05:56AM Syros Pharmaceuticals (SYRS) Acquires Clinical-Stage Drug Candidate, SY-2101, for Acute Promyelocytic Leukemia from Orsenix, LLC
Dec 5, 2020 12:31PM
Dec 5, 2020 12:31PM
Sep 9, 2020 08:35AM
Sep 9, 2020 08:31AM
Dec 18, 2019 09:27AM
Dec 18, 2019 08:57AM
Dec 18, 2019 07:15AM GBT Secures $150 Million Non-Dilutive Term Loan Financing
Dec 18, 2019 07:02AM
Dec 18, 2019 07:00AM
Nov 19, 2019 04:30PM
Nov 8, 2019 07:00AM
Oct 2, 2019 07:00AM
Jun 12, 2019 08:33AM
Jun 12, 2019 08:31AM Syros Announces Appointment of Alice T. Shaw to its Board of Directors
Jan 22, 2018 08:03AM
Jan 22, 2018 08:01AM
Jan 2, 2018 08:07AM
Jan 2, 2018 08:01AM
Dec 20, 2017 08:00AM
Nov 14, 2017 07:00AM
Nov 8, 2017 08:01AM Syros Reports Third Quarter 2017 Financial Results and Highlights Accomplishments and Upcoming Milestones
Sep 18, 2017 07:35AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All